Deferred Stenting in Patients With Anterior Wall STEMI

NAActive, not recruitingINTERVENTIONAL
Enrollment

185

Participants

Timeline

Start Date

April 3, 2018

Primary Completion Date

April 3, 2025

Study Completion Date

November 30, 2025

Conditions
Acute Myocardial Infarction With ST ElevationAnterior Wall Myocardial Infarction
Interventions
PROCEDURE

Immediate stenting

Abciximab (0.25㎎/㎏) intracoronary injection will be performed to all possible patients after guidewire has passed culprit lesion. Additional manual thrombus aspiration or balloon angioplasty can be performed by operator to achieve TIMI Ⅲ flow. When TIMI Ⅲ flow is achieved after these procedures, patient will be randomized to immediate stenting or deferred stenting group. In immediate stenting group, stenting will be done immediate after achieving TIMI III flow during initial procedure.

PROCEDURE

Deferred stenting

Abciximab (0.25㎎/㎏) intracoronary injection will be performed to all possible patients after guidewire has passed culprit lesion. Additional manual thrombus aspiration or balloon angioplasty can be performed by operator to achieve TIMI Ⅲ flow. When TIMI Ⅲ flow is achieved after these procedures, patient will be randomized to immediate stenting or deferred stenting group. In deferred stenting group, second stage procedure (stent implantation) will be done at 3 to 7 days after TIMI Ⅲ flow has achieved.

Trial Locations (1)

02841

Korea University Anam Hospital, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Abbott

INDUSTRY

collaborator

Samjin Pharmaceutical Co., Ltd.

INDUSTRY

lead

Korea University Anam Hospital

OTHER